Panic disorder and suicidality: is comorbidity with depression the key? |
|
Pathways of Association Between Childhood Irritability and Adolescent Suicidality |
|
Patterns of co-morbidity in male suicide completers. |
|
Perinatal adversity profiles and suicide attempt in adolescence and young adulthood: longitudinal analyses from two 20-year birth cohort studies |
|
Perinatal depression and DNA methylation of oxytocin-related genes: a study of mothers and their children. |
|
Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression |
|
Personality traits as correlates of suicide attempts and suicidal ideation in young adults |
|
PHAC and a national suicide prevention strategy. |
|
Pharmacogenetics and mood stabilization in bipolar disorder |
|
Pharmacogenomics of suicidal events |
|
Plasticity of the epigenome during early-life stress. |
|
Polyamines are implicated in the emergence of the embryo from obligate diapause |
|
Polyglutamine coding genes in bipolar disorder: lack of association with selected candidate loci |
|
Polyglutamine-containing proteins in schizophrenia. |
|
Polyglutamine tracts: no evidence of a major role in bipolar disorder |
|
Polymorphism in the cell division cycle 45 like gene and schizophrenia |
|
Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants |
|
Predicting suicide attempts in young adults with histories of childhood abuse |
|
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment |
|
Predisposition to treatment response in major depressive episode: A peripheral blood gene coexpression network analysis. |
|
Prefrontal inositol levels and implicit decision-making in healthy individuals and depressed patients |
|
Preventing suicide: where are we? |
|
Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide |
|
Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain |
|
Protective Factors in the Inuit Population of Nunavut: A Comparative Study of People Who Died by Suicide, People Who Attempted Suicide, and People Who Never Attempted Suicide. |
|
Psychiatric diagnoses in 3275 suicides: a meta-analysis |
|
Psychiatric risk factors for motor vehicle fatalities in young men. |
|
Psychiatric services utilization in completed suicides of a youth centres population |
|
PTPRD |
|
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome |
|
Quantifying RNA allelic ratios by microfluidic multiplex PCR and sequencing. |
|
Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors. |
|
Recent and lifetime utilization of health care services by children and adolescent suicide victims: a case-control study |
|
Regulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completers |
|
Regulation of BAZ1A and nucleosome positioning in the nucleus accumbens in response to cocaine |
|
Regulation of impulsive and aggressive behaviours by a novel lncRNA |
|
Repression of Astrocytic Connexins in Cortical and Subcortical Brain Regions and Prefrontal Enrichment of H3K9me3 in Depression and Suicide |
|
Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis |
|
Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity |
|
Restriction Enzyme Based Enriched L1Hs Sequencing (REBELseq): A Scalable Technique for Detection of Ta Subfamily L1Hs in the Human Genome |
|
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers |
|
Risk factor modifications and depression incidence: a 4-year longitudinal Canadian cohort of the Montreal Catchment Area Study |
|
Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression |
|
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction |
|
Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study. |
|
Role of Complex Epigenetic Switching in Tumor Necrosis Factor-α Upregulation in the Prefrontal Cortex of Suicide Subjects. |
|
Role of Tet1 and 5-hydroxymethylcytosine in cocaine action |
|
Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions |
|
Schizophrenia, Other Psychotic Disorders, and Suicidal Behaviour |
|
Self-critical perfectionism is associated with increases in sympathetic indicators in a controlled laboratory stress paradigm. |
|
Sensitive periods in epigenetics: bringing us closer to complex behavioral phenotypes |
|
Serotonin transporter gene promoter methylation in peripheral cells in healthy adults: Neural correlates and tissue specificity |
|
Service use and unmet needs in youth suicide: a study of trajectories |
|
Sex Differences in Nucleus Accumbens Transcriptome Profiles Associated with Susceptibility versus Resilience to Subchronic Variable Stress. |
|
Sex-specific transcriptional signatures in human depression. |
|
Sexual orientation and gender identity in youth suicide victims: an exploratory study |
|
Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons |
|
Sleep quality is associated with vasopressin methylation in pregnant and postpartum women with a history of psychosocial stress |
|
SNAT1 and a family with high rates of suicidal behavior. |
|
Social stress induces neurovascular pathology promoting depression |
|
SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's Disease. |
|
Spectroscopy markers of suicidal risk and mental pain in depressed patients. |
|
Stalled developmental programs at the root of pediatric brain tumors |
|
STin2 variant and family history of suicide as significant predictors of suicide completion in major depression |
|
Stress resilience is promoted by a Zfp189-driven transcriptional network in prefrontal cortex |
|
Structural brain abnormalities in patients with type I bipolar disorder and suicidal behavior. |
|
Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects |
|
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement |
|
Suicide Among Inuit: Results From a Large, Epidemiologically Representative Follow-Back Study in Nunavut |
|
Suicide amongst the Inuit of Nunavut: An Exploration of Life Trajectories |
|
Suicide and assisted dying in dementia: what we know and what we need to know. A narrative literature review |
|
Suicide and no axis I psychopathology |
|
Suicide and suicide behaviors: A review of transcriptomics and multiomics studies in psychiatric disorders |
|
Suicide and the polyamine system |
|
Suicide attempts in major depressed patients with personality disorder |
|
Suicide cases in New Brunswick from April 2002 to May 2003: the importance of better recognizing substance and mood disorder comorbidity |
|
Suicide neurobiology |
|
Suicide risk assessment and intervention in people with mental illness |
|
Suicide, schizophrenia, and schizoid-type psychosis: role of life events and childhood factors. |
|
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report |
|
Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder |
|
Systematic services audit of consecutive suicides in New Brunswick: the case for coordinating specialist mental health and addiction services |
|
Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression |
|